AIM and NASN SLV Promotional Toolkit: School-Located Vaccination Clinics
AIM and NASN partnered to produce informational resources regarding School-Located Vaccination Clinics and to share best practices.
Engaging Rural Pharmacies to Increase Vaccine Access and Confidence Webinar
AIM hosted Engaging Rural Pharmacies to Increase Vaccine Access and Confidence Webinar with Laura Lee Hall, Ph.D., President of the Center for Sustainable Health Care Quality and Equity.
AIM and NASN SLV Special Supplement
AIM and the National Association of School Nurses (NASN) are excited to share the NASN School Nurse January 2022 Special Supplement “School-Located Vaccination (SLV) Clinics in the Era of COVID-19.”
COVID-19 Vaccine Update and Updated Quarantine/Isolation Recommendations
This e-learning module was developed by the iREACH team to provide a suite of materials containing comprehensive information on flu disease and flu vaccine.
Holding a Joint Flu and COVID-19 Vaccination Clinic Webinar
This iREACH webinar featured presentations from REACH recipient organizations on how to successfully hold a combined flu and COVID-19 vaccination clinic.
Promising Practices Webinars
On November 5, 2019, AIM partnered with Sanofi Pasteur to host a webinar reviewing how the changing healthcare landscape impacts providers’ quality improvement (QI) efforts and how these changes can help immunization programs increase immunization goals rates, improve IIS participation,…
AIM Leadership Training
Strategic planning can be stressful—especially if you don’t know where to start or what tools to use. This workshop will help you tackle challenges head-on. You’ll get a variety of resources, your relationship building time and leave this session with…
First Approved Oral Antiviral Pill for COVID-19 Disease
This talking points document, available in Spanish and English, was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to provide detailed information on the first approved oral antiviral pill for COVID-19 disease.
December 2021 ACIP Recommendation on Johnson & Johnson Vaccine
This talking points document was developed by the iREACH Subject Matter Experts to provide information on the ACIP recommendation regarding the Johnson & Johnson COVID-19 vaccine.
Lessons from the First Year of COVID-19 Vaccination, and What’s Next?
AIM Policy Consultant Brent Ewig, AIM Executive Director Claire Hannan, and ASTHO CEO Michael Fraser on COVID-19 vaccination and what lies ahead.